Document Detail


Assisted reproduction technologies alter steroid delivery to the mouse fetus during pregnancy.
MedLine Citation:
PMID:  21193037     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Assisted reproduction technologies (ART) include in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI), and are common treatments for infertility. Although generally successful, ART warrant further investigations due to emerging perinatal issues, especially low birth weight. Herein we extend our previous work demonstrating higher steroid clearance in murine ART placentas by examining steroid biosynthesis and the directional flow of steroids in the maternal-placental-fetal units. The activities of the major steroidogenic enzymes 3β-hydroxysteroid dehydrogenase (3β-HSD) and cytochrome P450 17-αhydroxylase (CYP17) were assessed in maternal liver and ovaries and fetal livers as were levels of cholesterol, progesterone, estrone (E1), and estradiol (E2) in the maternal, placental and fetal units. No structural abnormalities were found in placentas from ART. Although ART increased 3β-HSD activity in maternal livers, there were no other changes in 3β-HSD- or CYP17-mediated steroidogenesis. Cholesterol levels were significantly lower in maternal livers of ICSI pregnancies and in placentas from both IVF and ICSI pregnancies but not altered in the fetal livers. Progesterone levels were higher in maternal and fetal livers in IVF and ICSI, respectively, but were significantly lowered in ICSI placentas, compared to normal fertilization. For estrogenic hormones, no differences in E1 or E2 levels were observed in maternal livers but ICSI significantly increased both E1 and E2 levels in placentas while both IVF and ICSI significantly lowered E1 but raised E2 levels in fetal livers. In summary, while steroid production was normal, steroid diffusion/flow from mother to fetus was altered in murine pregnancies conceived by ART. This appears to occur, at least in part; through placental mechanisms. Impaired cholesterol and steroid transfer may affect correct regulation of fetal growth and development.
Authors:
Jefferey M Raunig; Yasuhiro Yamauchi; Monika A Ward; Abby C Collier
Related Documents :
7800857 - Down regulation of the angiotensin ii receptor subtype at2 in human myometrium during p...
21367667 - The origins and end-organ consequence of pre-eclampsia.
21473677 - Pregnancy outcomes in women with elevated levels of fetal hemoglobin.
9043147 - Estradiol and progesterone release form biodegradable d,l-lactide and epsilon-caprolact...
8743167 - Expression pattern of cytokines in the different compartments of the feto-maternal unit...
18834337 - Non-cirrhotic portal hypertension and pregnancy outcome.
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural     Date:  2010-12-28
Journal Detail:
Title:  The Journal of steroid biochemistry and molecular biology     Volume:  126     ISSN:  1879-1220     ISO Abbreviation:  J. Steroid Biochem. Mol. Biol.     Publication Date:  2011 Aug 
Date Detail:
Created Date:  2011-06-13     Completed Date:  2011-08-16     Revised Date:  2014-09-08    
Medline Journal Info:
Nlm Unique ID:  9015483     Medline TA:  J Steroid Biochem Mol Biol     Country:  England    
Other Details:
Languages:  eng     Pagination:  26-34     Citation Subset:  IM    
Copyright Information:
Copyright © 2011 Elsevier Ltd. All rights reserved.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
3-Hydroxysteroid Dehydrogenases
Animals
Cholesterol / metabolism
Estradiol / analysis,  metabolism*
Estrone / analysis,  metabolism*
Female
Fertilization in Vitro / adverse effects*
Fetus / metabolism*
Liver / enzymology,  metabolism
Maternal-Fetal Exchange*
Mice
Ovary / enzymology,  metabolism
Placenta / metabolism
Pregnancy
Progesterone / analysis,  metabolism*
Sperm Injections, Intracytoplasmic / adverse effects*
Steroid 17-alpha-Hydroxylase
Grant Support
ID/Acronym/Agency:
HD058059/HD/NICHD NIH HHS; P20 RR024206/RR/NCRR NIH HHS; P20 RR024206-03/RR/NCRR NIH HHS; RR024206/RR/NCRR NIH HHS
Chemical
Reg. No./Substance:
2DI9HA706A/Estrone; 4G7DS2Q64Y/Progesterone; 4TI98Z838E/Estradiol; 97C5T2UQ7J/Cholesterol; EC 1.1.-/3-Hydroxysteroid Dehydrogenases; EC 1.14.99.9/Steroid 17-alpha-Hydroxylase
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The development of a whole-cell based medium throughput screening system for the discovery of human ...
Next Document:  Associations between polymorphisms in glucuronidation and sulfation enzymes and sex steroid concentr...